Is anyone else looking at the state of U500 vials now that they are being sunset ? only the pens will be available ?

Will you change your formulary ?
thanks for any help !

laura

How are your hospitals approaching PPE when handling body fluids for patients on estrogens (birth control)?

Background: We configured Epic to flag patients who have hazardous home meds. Since estrogens are NIOSH Table 1, nurses were presented a banner saying that they need to be wearing PPE when handling bodily fluids. This has spurred a lot of internal discussion as we determine the risk to staff, and appropriate PPE.

Thank you!

Our hypertonic saline policy currently requires that sodium chloride 23.4% be administered by a provider. Do you have similar restrictions for who can administer and/or require a provider to be onsite?

I would love if you could let me know in this quick, anonymous poll: https://forms.office.com/r/jUkisNusRF

I will post results back to the forum.

Thank you!

Hi everyone
All members, I hope you all are doing good work.
My topic today is and I also have a query that how to calculate the total number of opportunity for medication errors.

kindly suggest me the Clinical Audit Topics and Best guidelines.

Thanks
PRAVEEN KUMAR
CLINICAL PHARMACOLOGIST MSO
INIDA 7015551545

Hello, my institution is evaluating whether to remove the total dose from our outpatient prescription labels and/or after visit summaries (AVS), and instead only include the number of tablets/milliliters/etc the patient should take. The concern is that patients may misread "5 mg" as "5 tablets" and take the wrong dose, but we also have some concerns with not communicating the total dose to the patient.

Our current formatting for prescription labels and AVS is the same: Take one tablet (5 mg) by mouth daily.

We are considering changing to: Take one tablet by mouth daily.

Hi Everyone
There is currently quite a bit of information on here regarding dispensing of low doses of enoxaparin (< 10 mg) for pediatric patients. For inpatients we currently dispense enoxaparin doses < 10mg utilizing the 20 mg/mL concentration using a fixed needle 0.5 mL TB syringe. When these patients discharge home and need enoxaparin it seems we are sending them home with the 100 mg/mL enoxaparin vials and teaching parents to use insulin syringes for doses < 10 mg.

What are other institutions dosing when patients go home on low dose enoxaparin (< 10 mg)?

We continue to have reports of IV calcium and IV phosphate being ran in the same line with some precipitation noted. We have instructions on both orders indicating to avoid running theses two in the same line and have clinical advisories at the pump as well. Are there any other strategies people have used to try and help prevent this from happening? In a couple cases the IV calcium and IV phosphate had the same administration due time. Is it an expectation that pharmacists are evaluating this upon verifcation and retiming if needed?

Hi everyone, as we all are MSOS members. And we all are working well in different places. My concern today is if someone can guide me as to how we can improve the quality and reduce medication errors. If anyone has worked on any program in his/her hospital till now then please share it here.

PRAVEEN KUMAR
CAPITOL HOSPITAL , JALANDHAR PUNJAB INIDA
7015551545
MSO, CLINICAL PHARMACOLOGIST

Reflecting on a look-alike error we had with dexamethasone and ketorolac vials that are nearly identical from the back and top, I had a radical idea that I would like to share with everyone.

Wouldn't it be great if all medication vial caps were plain white?

We all know that vial cap color is an unreliable means to identify a medication. There are more injectable drugs than there are colors, and there is no standardization across manufacturers for the choice of color. Despite this obvious fact, many people still do rely on vial cap color for identification.

At my facility, we had three incidences (three different patients) where Rocuronium was not paralyzing patients as intended (i.e. anesthesia has had to use twice the dose of Rocuronium from manufacturer below as opposed to the standard dose from other manufacturer).

I have already submitted a case with the manufacturer, and in the interim, we have sequestered the lot and replaced with another manufacturer.

Manufacturer: Piramal Critical Care
Lot: 24410013

Just wanted to see if any one else has received similar feedback from using this manufacturer?